Swing Therapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Swing Therapeutics, Inc.
Private Company Edition: While the tough state of financing for publicly traded drug developers continues, venture capital firms and private biopharma companies revealed billions of dollars in new VC funds and start-up financings, including $100m-plus mega-rounds for Tessa, Alladapt and ImCheck.
- Medical Devices
- Disease Management
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.